The Clinic of Hepatobiliary and Transplant Surgery offers interdisciplinary treatment of tumours of the liver, biliary tract and gall bladder and liver, kidney and pancreas transplants. It is led by Prof Björn Nashan and is the largest transplant centre in Northern Germany, with nearly 200 transplants performed.
Clinic of Hepatobiliary and Transplant Surgery
Prof Nashan is Professor of Surgery and leads the Clinic of Hepatobiliary and Transplant Surgery at UKE Hamburg and is also Professor of Microbiology and Immunology, Dalhousie University, Halifax, Canada.
Prof Björn Nashan
The main part of his clinical work is devoted to extended liver surgery in patients with primary and secondary lesions of the liver, as well as malignancies of the bile duct, i.e. cholangiocarcinoma and Klatzkin tumours. This work is done on an interdisciplinary level including specialists from hepatology, oncology and radiology.
Benign liver tumours and gall bladder tumours
One focus of treatment is the advancement of the minimally invasive therapy for benign liver tumours and tumours of the gall bladder. These are complex tumours to treat, requiring innovative therapeutic approaches, including 3D reconstruction and navigation.
Within the framework of the University Cancer Center Hamburg (UCCH), UKE has established the first interdisciplinary special consultation hour for patients with liver and biliary tract tumours. The goal is to assess patients in a qualified manner, with the help of many specialists during a single appointment and to initiate immediate treatment.
Research centre
Focus areas of research include transplantation immunology, immunogenetics, tissue engineering, fundamental oncological research (cancer of the liver and biliary tract, metastases in the liver), immunosuppression in organ transplants, developing 3D-guided navigation procedures for liver resection and clinical trials for the treatment of patients with liver metastases.
The Clinic employs 19 doctors with various specialisations and 22 nurses attend to the well-being of patients. Each year the Clinic treats approximately 700 inpatients and more than 6,000 outpatients.
UKE established Europe’s first living donor liver donation programme and is the largest pediatric liver transplant centre in Europe, conducting 20 paediatric liver transplants per year. It performs transplants on adults and children from all over Germany and from abroad and almost all German scientific clinical publications on liver transplantation in children stem from UKE.
Pioneering Transplant Department
The aim of the UKE Transplant Centre is to provide interdisciplinary clinical and scientific support to all transplant recipients and organ donors. Patients are cared for jointly by the transplant surgery and the nephrology and paediatric nephrology departments.
Transplant psychologists offer support to all kidney recipients and donors.
Patients with high immunologic risk
One of the focus areas of the clinic is transplantation in patients with high immunologic risk. This includes transplantation of living donor organs across blood groups (ABO incompatible transplants) and transplantation of highly sensitised recipients (desensitisation program).
Liver transplants
Note - for international patients who are not members of the Eurotransplant zone (Germany, Belgium, the Netherlands, Austria, Luxembourg, Croatia, Slovenia), UKE can only offer living donor transplants - i.e. a suitable organ donor from the patient’s family must be brought along, who will donate part of his liver.
In adult recipients this is usually the right liver lobe, while for paediatric recipients liver segments II and III are usually sufficient. Since the liver has the ability to regenerate quickly, the donated part of the liver will grow back within a few weeks.
UKE has an extensive and active liver transplant program, with more than 1,700 liver transplantations performed between 1990 and 2009 (approximately 1,100 in adults and 600 in children).
Selection of liver patients and donors
Recipients who are accepted as patients after sending their medical documents may travel to Hamburg for further evaluation.
Living donors who are accepted after sending us the pre-evaluation form should arrive in Hamburg as outpatients. Additional examinations will be carried out, taking into account the individual needs of the donor. Normally, the evaluation phase takes about 2 weeks, during which it is decided whether the donor is really a good match. If so, a surgery date can be fixed.
Living donors must be a relative of the recipient, between 18-60 years old, with no obesity or previous deep vein thrombosis or pulmonary embolism.
Aftercare
After a liver transplant, the recipient usually remains hospitalised for 4-6 weeks. Discharge is followed by an outpatient aftercare period of at least 4-6 weeks to allow the body to adjust to the new drugs that suppress the immune system and prevent rejection of the liver.
After a living donation, the donor remains hospitalised for approximately 7-14 days. Subsequently he is treated in the outpatient clinic and after 4-6 weeks travels back to his home country.
UKE, performs more than 100 kidney transplants per year, for both adults and children and by 2010 the hospital had performed 223 paediatric transplants.
Selection of kidney patients and donors
Kidney transplants
Obtaining a kidney transplant is the only curative treatment option for end-stage renal insufficiency. Common causes of terminal renal insufficiency are diabetes mellitus, hypertension (high blood pressure), glomerulonephritis, interstitial nephritis and polycystic kidney degeneration.
Note - international patients who are not members of the Eurotransplant zone (Germany, Belgium, the Netherlands, Austria, Luxembourg, Croatia, Slovenia) will not receive a cadaver kidney transplant via Eurotransplant and must bring a matching living donor.
Almost all patients with severe kidney problems stand to benefit from a transplant. There is no absolute age limit. A kidney transplant must always be considered if a patient requires dialysis, because compared with dialysis it leads to better survival rates and much better quality of life.
It is important that diseases which could endanger the patient during or after transplantation are excluded, during a detailed preliminary examination. Such conditions include particularly severe untreated infections, uncured tumours and severe heart, vascular, and pulmonary diseases.
For a living kidney donation, donor and recipient need not have the same blood type. However close attention must be paid to histocompatibility, particularly with patients who have received a transplant before.
For the donor there is no age limit. The donor must be healthy and free of major risk factors for future kidney disease (e.g., diabetes).
After a kidney transplant, the recipient usually remains hospitalised for 7-14 days. Discharge is followed by an outpatient aftercare period of at least 4-6 weeks to allow the body to adjust to the new drugs that suppress the immune system and prevent rejection of the kidney.
Aftercare
After a living donation, the donor remains hospitalised for approximately 7 days.
Combined transplants
UKE also offers combined kidney/pancreas and liver/kidney transplants.
University Medical Centre, Hamburg, Germany
Universitätsklinikum Hamburg-Eppendorf (UKE)
For information on the University Medical Centre, Hamburg-Eppendorf, visit the UKE page.
All patients and their families are supported with translation service, airport shuttle, driver service and many other administrative services provided by the International Office of the UKE.
International patients
Enquiries
Make an enquiry to UKE Hamburg. Your enquiry will be passed automatically to UKE, who will respond to you directly.
Make an enquiry to UKE Hamburg. Your enquiry will be passed automatically to UKE, who will respond to you directly.
www.a1med.co.uk
S P E C I A L I S T T R E A T M E N T S P A G E S
© PPM Consult Ltd . 2006-2012. All rights reserved
Important note to all patients
PPM Consult Ltd. promotes selected clinics and certain specialities within individual hospitals in association with Medilux Healthcare Ltd. (MHL), where we believe the standards of care or medical equipment to be exceptional. We provide you with general information but we cannot advise or enter into correspondence about individual cases and we do not arrange or facilitate treatments. We shall not be responsible for the outcome of any treatment or failure to diagnose or treat and we recommend that all patients obtain professional medical advice on their proposed treatments.